Revenue YoY
+8.06%
Operating Income YoY
+5.09%
Net Income YoY
-61.20%
Net Margin Δ
-2083 bps
Net income bridge for Abbott Laboratories (ABT) — TTM through Q2 2026 vs TTM through Q2 2025
Δ Net income: -$8.55B-61.20%
Profit bridge breakdown for Abbott Laboratories (ABT) — TTM through Q2 2026 vs TTM through Q2 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $14B | — |
| Revenue | $3.48B | +40.6% |
| Cost of Revenue | $230M | +2.7% |
| Operating Expenses | -$3.32B | -38.8% |
| Other Income / Expense | -$771M | -9.0% |
| Income Tax | -$8.17B | -95.5% |
| Net Income | $5.43B | — |
- Prior Net Income$14B
- Revenue$3.48B
- Cost of Revenue$230M
- Operating Expenses-$3.32B
- Other Income / Expense-$771M
- Income Tax-$8.17B
- Net Income$5.43B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.44% TTM
- Dividend Profile2.47% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.